Jain Global LLC Kymera Therapeutics, Inc. Transaction History
Jain Global LLC
- $3.35 Trillion
- Q4 2024
A detailed history of Jain Global LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Jain Global LLC holds 26,456 shares of KYMR stock, worth $996,068. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,456Holding current value
$996,068% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.5MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$259 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$226 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$200 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$194 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$194 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.06B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...